Darmiyan: Testing a Novel Software for Early Detection of Alzheimer’s Disease

Diagnostic Study

Get in touch about this study
What is the study about?

The goal of this study is to find out whether Darmiyan is an effective tool for diagnosing Alzheimer’s disease earlier. Darmiyan is a new software that can identify brain changes that may not be visible on traditional MRI brain scans. This project includes two studies to test how accurate and reliable Darmiyan is in predicting and detecting Alzheimer’s disease.

Eligibility – Who can participate?

Participants must:

  • Be able to speak English to complete neuropsychological testing

  • Have a caregiver who can come in and answer questions

  • Be 50 years of age or older

  • Either have no memory complaints, have mild cognitive impairment, or Alzheimer’s disease

Time requirement
  • Study 1 (a prospective study): A baseline visit with follow up at 4 to 9 months

  • Study 2 (a retrospective study): One visit following recruitment through chart review

TDRA study investigator

Dr. Morris Freedman

More information


TDRA Site:


Address: 3560 Bathurst St, North York, ON M6A 2E1

Age Group:

, , , , , ,

Target Population:

, ,

Do you have questions about research studies you saw on this page? Please contact tdra@utoronto.ca


The listing of a study on the Toronto Dementia Network (TDN) is for informational purposes only. The safety, efficacy or scientific validity of the studies listed here have not been evaluated by The Alzheimer Society of Toronto (AST) or the Toronto Dementia Research Alliance (TDRA). The TDRA is an academic coalition among the University of Toronto and four memory clinics across Toronto at Baycrest, the Centre for Addiction and Mental Health, Sunnybrook Health Sciences Centre, and the University Health Network. The information collected will be kept and guarded by TDRA. Choosing to participate in a study is an important personal decision. Before you participate in a study, you should make sure you understand the risks and potential benefits and discuss all options with your health care provider(s).